The 2026-06-17 single-patient Alzheimer's-psilocybin reversal claim is publicly walked back, contextualized, or corrected by the originating party or major coverage within four weeks.

A report from mid-June 2026 claimed one single patient with Alzheimer's appeared to dramatically improve after psilocybin treatment. One patient is not enough to draw any real conclusions — it could be coincidence, a good day, or a measurement fluke. Claims like this almost always get quietly corrected or heavily qualified once scientists and journalists look more carefully, usually within a month.

Single-patient reversal claims lack statistical power and routinely face correction once scrutinized. Industry hype reflex tends to trigger a sober correction cycle within weeks.